Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy.

Hdl Handle:
http://hdl.handle.net/10147/622506
Title:
Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy.
Authors:
Cagney, Daniel N; Dunne, Mary; O'Shea, Carmel; Finn, Marie; Noone, Emma; Sheehan, Martina; McDonagh, Lesley; O'Sullivan, Lydia; Thirion, Pierre; Armstrong, John
Citation:
Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy. 2017, 17 (1):60 BMC Urol
Journal:
BMC urology
Issue Date:
1-Aug-2017
URI:
http://hdl.handle.net/10147/622506
DOI:
10.1186/s12894-017-0250-2
PubMed ID:
28764689
Abstract:
Our aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT).
Item Type:
Article
Language:
en
Keywords:
PROSTATE CANCER; RADIOTHERAPY
ISSN:
1471-2490

Full metadata record

DC FieldValue Language
dc.contributor.authorCagney, Daniel Nen
dc.contributor.authorDunne, Maryen
dc.contributor.authorO'Shea, Carmelen
dc.contributor.authorFinn, Marieen
dc.contributor.authorNoone, Emmaen
dc.contributor.authorSheehan, Martinaen
dc.contributor.authorMcDonagh, Lesleyen
dc.contributor.authorO'Sullivan, Lydiaen
dc.contributor.authorThirion, Pierreen
dc.contributor.authorArmstrong, Johnen
dc.date.accessioned2017-08-11T11:53:23Z-
dc.date.available2017-08-11T11:53:23Z-
dc.date.issued2017-08-01-
dc.identifier.citationHeterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy. 2017, 17 (1):60 BMC Urolen
dc.identifier.issn1471-2490-
dc.identifier.pmid28764689-
dc.identifier.doi10.1186/s12894-017-0250-2-
dc.identifier.urihttp://hdl.handle.net/10147/622506-
dc.description.abstractOur aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT).en
dc.language.isoenen
dc.rightsArchived with thanks to BMC urologyen
dc.subjectPROSTATE CANCERen
dc.subjectRADIOTHERAPYen
dc.titleHeterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy.en
dc.typeArticleen
dc.identifier.journalBMC urologyen
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.